5 reports

The molecules developed by companies in Phase II, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Therapy
  • Australia
  • Product Initiative

OA is a highly prevalent and disabling pathology.

  • Chronic Pain
  • Musculoskeletal Disorder
  • Therapy
  • Australia
  • Product Initiative

Severe RRV (Ross River virus)induced joint pathology, including thinning of articular cartilage and loss of proteoglycans in the cartilage matrix, was diminished with PPS treatment.

  • Clinical Trial
  • Musculoskeletal Disorder
  • Therapy
  • Australia
  • Galapagos NV

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Biopharmaceutical
  • Musculoskeletal Disorder
  • Australia
  • M&A
  • Paradigm Biopharmaceuticals Ltd.
  • BRM-521 - DRUG PROFILE
  • 4P-004 - DRUG PROFILE

Philogen develops drugs for treatment of severe pathologies such as cancer, rheumatoid arthritis and age-related macular degeneration.

  • Musculoskeletal Disorder
  • Australia
  • United States
  • Product Initiative
  • Can-Fite BioPharma Ltd.